Cite

HARVARD Citation

    Ning, X. et al. (2022). CD43 is an adverse prognostic factor in newly diagnosed multiple myeloma. Leukemia & lymphoma. 63 (11), pp. 2573-2578. [Online]. 
  
Back to record